ReviewCancers2024
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation.
Luca Potestio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCancers2024
Luca Potestio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.